Ramius Advisors LLC Allakos Inc. Transaction History

Ramius Advisors LLC

  • $0
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020
SELL
$44.04 - $80.69 $1.37 Million - $2.51 Million
-31,155 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$44.49 - $93.39 $36,170 - $75,926
813 Added 2.68%
31,155 $1.39 Million
Q4 2019

Feb 14, 2020
BUY
$66.49 - $137.73 $2.02 Million - $4.18 Million
30,342 New
30,342 $2.89 Million

Others Institutions Holding ALLK

# of Institutions
82
Shares Held
64.7M
Call Options Held
47.1K
Put Options Held
1K
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $91.5M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Ramius Advisors LLC Portfolio

Follow Ramius Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ramius Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ramius Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email